TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Fujirebio Diagnostics AB
Closing information (x1000 SEK)
Closing information | 2023/03 (consolidated) | 2022/03 (consolidated) | 2021/03 (consolidated) |
Turnover | 265,132 | 250,221 | |
Financial expenses | 474 | 29,223 | |
Earnings before taxes | 139,372 | 100,594 | |
EBITDA | 144,735 | 134,371 | |
Total assets | 615,270 | 465,136 | |
Current assets | 296,982 | 398,114 | |
Current liabilities | 63,557 | 28,259 | |
Equity capital | 545,028 | 431,580 | |
- share capital | 641 | 641 | |
Employees (average) | 86 | 75 | 71 |
Financial ratios
Fiscal year | 2023/03 (consolidated) | 2022/03 (consolidated) | 2021/03 (consolidated) |
Solvency | 88.6% | 92.8% | |
Turnover per employee | 3,535 | 3,524 | |
Profit as a percentage of turnover | 52.6% | 40.2% | |
Return on assets (ROA) | 22.7% | 27.9% | |
Current ratio | 467.3% | 1408.8% | |
Return on equity (ROE) | 25.6% | 23.3% | |
Change turnover | 14,911 | -25,230 | |
Change turnover % | 17% | 6% | -9% |
Chg. No. of employees | 11 | 4 | 4 |
Chg. No. of employees % | 15% | 6% | 6% |
Total value of public sale
Fiscal year | 2023/03 (consolidated) | 2022/03 (consolidated) | 2021/03 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.